CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives final approval from USFDA for Liothyronine Sodium Tablets23-01-2021
23-01-2021
CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate22-01-2021
Cadila Healthcare Q3 PAT seen up 37.6% YoY to Rs. 373.9 cr: Prabhudas Lilladher
Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 3,638.1 crore, according to Prabhudas Lilladher.18-01-2021
CADILA HEALTHCARE LTD. - 532321 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Dhaval N SoniDesignation :- Company Secretary and Compliance Officer18-01-2021
Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec
The stock price of Cadila Healthcare has broken out from the consolidation which held for last three weeks15-01-2021
COVID-19 vaccine | India's Cadila to develop 100-150 million doses of ZyCoV-D by 2021-end
Cadila Healthcare, in a statement issued on January 12, reiterated that its vaccine candidate - ZyCoV-D - has demonstrated promising results in the first and second phase of clinical trials.12-01-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Attaching Investor Presentation12-01-2021
CADILA HEALTHCARE LTD. - 532321 - Investor Conference
Company is going to participate in J P Morgan Healthcare Conference on January 11 and 12, 2021.11-01-2021
CADILA HEALTHCARE LTD. - 532321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate for the quarter ended on December 31, 2020.08-01-2021
CADILA HEALTHCARE LTD. - 532321 - Shareholding for the Period Ended December 31, 2020
Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here08-01-2021